These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 17923483

  • 1. Regulation of dopamine transporter function and cell surface expression by D3 dopamine receptors.
    Zapata A, Kivell B, Han Y, Javitch JA, Bolan EA, Kuraguntla D, Jaligam V, Oz M, Jayanthi LD, Samuvel DJ, Ramamoorthy S, Shippenberg TS.
    J Biol Chem; 2007 Dec 07; 282(49):35842-54. PubMed ID: 17923483
    [Abstract] [Full Text] [Related]

  • 2. D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism.
    Bolan EA, Kivell B, Jaligam V, Oz M, Jayanthi LD, Han Y, Sen N, Urizar E, Gomes I, Devi LA, Ramamoorthy S, Javitch JA, Zapata A, Shippenberg TS.
    Mol Pharmacol; 2007 May 07; 71(5):1222-32. PubMed ID: 17267664
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism.
    Kivell B, Uzelac Z, Sundaramurthy S, Rajamanickam J, Ewald A, Chefer V, Jaligam V, Bolan E, Simonson B, Annamalai B, Mannangatti P, Prisinzano TE, Gomes I, Devi LA, Jayanthi LD, Sitte HH, Ramamoorthy S, Shippenberg TS.
    Neuropharmacology; 2014 Nov 07; 86():228-40. PubMed ID: 25107591
    [Abstract] [Full Text] [Related]

  • 6. Novel roles for β-arrestins in the regulation of pharmacological sequestration to predict agonist-induced desensitization of dopamine D3 receptors.
    Min C, Zheng M, Zhang X, Caron MG, Kim KM.
    Br J Pharmacol; 2013 Nov 07; 170(5):1112-29. PubMed ID: 23992580
    [Abstract] [Full Text] [Related]

  • 7. Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake.
    Castro-Hernández J, Afonso-Oramas D, Cruz-Muros I, Salas-Hernández J, Barroso-Chinea P, Moratalla R, Millan MJ, González-Hernández T.
    Neurobiol Dis; 2015 Feb 07; 74():325-35. PubMed ID: 25511804
    [Abstract] [Full Text] [Related]

  • 8. Prolonged dopamine D3 receptor stimulation promotes dopamine transporter ubiquitination and degradation through a PKC-dependent mechanism.
    Luis-Ravelo D, Fumagallo-Reading F, Castro-Hernandez J, Barroso-Chinea P, Afonso-Oramas D, Febles-Casquero A, Cruz-Muros I, Salas-Hernandez J, Mesa-Infante V, Rodriguez-Nuñez J, Gonzalez-Hernandez T.
    Pharmacol Res; 2021 Mar 07; 165():105434. PubMed ID: 33484816
    [Abstract] [Full Text] [Related]

  • 9. Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptor.
    Joyce JN, Woolsey C, Ryoo H, Borwege S, Hagner D.
    BMC Biol; 2004 Oct 11; 2():22. PubMed ID: 15473914
    [Abstract] [Full Text] [Related]

  • 10. Dopamine transporter is downregulated and its association with chaperone protein Hsc70 is enhanced by activation of dopamine D3 receptor.
    Chang PK, Chien KY, Chen JC.
    Brain Res Bull; 2020 Dec 11; 165():263-271. PubMed ID: 33049353
    [Abstract] [Full Text] [Related]

  • 11. D3 dopamine receptor signals to activation of phospholipase D through a complex with Rho.
    Everett PB, Senogles SE.
    J Neurochem; 2010 Feb 11; 112(4):963-71. PubMed ID: 20021566
    [Abstract] [Full Text] [Related]

  • 12. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
    Glennon JC, Van Scharrenburg G, Ronken E, Hesselink MB, Reinders JH, Van Der Neut M, Long SK, Feenstra RW, McCreary AC.
    Synapse; 2006 Dec 15; 60(8):599-608. PubMed ID: 17001660
    [Abstract] [Full Text] [Related]

  • 13. The D(3) dopamine receptor inhibits dopamine release in PC-12/hD3 cells by autoreceptor signaling via PP-2B, CK1, and Cdk-5.
    Chen PC, Lao CL, Chen JC.
    J Neurochem; 2009 Aug 15; 110(4):1180-90. PubMed ID: 19522735
    [Abstract] [Full Text] [Related]

  • 14. Quinpirole-induced 50 kHz ultrasonic vocalization in the rat: role of D2 and D3 dopamine receptors.
    Brudzynski SM, Komadoski M, St Pierre J.
    Behav Brain Res; 2012 Jan 15; 226(2):511-8. PubMed ID: 22015714
    [Abstract] [Full Text] [Related]

  • 15. Rapid regulation of dopamine transporters by tyrosine kinases in rat neuronal preparations.
    Hoover BR, Everett CV, Sorkin A, Zahniser NR.
    J Neurochem; 2007 Jun 15; 101(5):1258-71. PubMed ID: 17419806
    [Abstract] [Full Text] [Related]

  • 16. Dopamine D2 receptor stimulation of mitogen-activated protein kinases mediated by cell type-dependent transactivation of receptor tyrosine kinases.
    Wang C, Buck DC, Yang R, Macey TA, Neve KA.
    J Neurochem; 2005 May 15; 93(4):899-909. PubMed ID: 15857393
    [Abstract] [Full Text] [Related]

  • 17. Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D2 receptor: analysis of dopamine receptor expression, location, development, and function in wild-type and knock-out mice.
    Li ZS, Schmauss C, Cuenca A, Ratcliffe E, Gershon MD.
    J Neurosci; 2006 Mar 08; 26(10):2798-807. PubMed ID: 16525059
    [Abstract] [Full Text] [Related]

  • 18. Increased desensitization of dopamine D₂ receptor-mediated response in the ventral tegmental area in the absence of adenosine A(2A) receptors.
    Al-Hasani R, Foster JD, Metaxas A, Ledent C, Hourani SM, Kitchen I, Chen Y.
    Neuroscience; 2011 Sep 08; 190():103-11. PubMed ID: 21669258
    [Abstract] [Full Text] [Related]

  • 19. Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors.
    Watts VJ, Neve KA.
    Mol Pharmacol; 1996 Oct 08; 50(4):966-76. PubMed ID: 8863843
    [Abstract] [Full Text] [Related]

  • 20. Antipsychotics with inverse agonist activity at the dopamine D3 receptor.
    Griffon N, Pilon C, Sautel F, Schwartz JC, Sokoloff P.
    J Neural Transm (Vienna); 1996 Oct 08; 103(10):1163-75. PubMed ID: 9013403
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.